Bone Degeneration Therapeutics Market
Osteoporosis – characterized by existence of porous bones may lead to fractures
There are two levels of bone loss that can result in an increased risk of fractures. Osteoporosis and osteopenia constitute two levels of bone loss. Osteopenia is considered as loss of bone material density, which indicates thinning of bones. Osteoporosis is a bone degeneration condition characterized by the existence of porous bones and it develops with time as bones slowly lose minerals, structure, and density, resulting in weaker bones. Eventually, osteoporosis leads to bent posture, cracked bones, and loss of height.
Excessive bone degeneration results in fragile bones that are highly susceptible to fracture. There are several tests such as bone densitometers and dual energy x-ray absorptiometry scans performed to determine the density of bones. Stimulation of soft tissues and cartilage repair with prolotherapy represents some of the ways of alleviating pain resulting from degenerative bone disorders.
Request a sample copy of this report@
Increasing diabetes incidence and rising obesity driving growth of the bone degeneration therapeutics market
Factors such as increased physical inactivity, rising obesity, and increasing rate of diabetes are fueling growth of the bone degeneration therapeutics market. According to World Health Organization (WHO) around 422 million people worldwide suffered from diabetes in 2014. Increasing number of diabetic patients is fueling growth of the bone degeneration therapeutics market.
Various products in research pipeline to augment the bone degeneration therapeutics market growth
Bone degeneration therapeutics market can be segmented by treatment and application. By treatment, the bone degeneration therapeutics market can be segmented into device, drug, and surgery. Braces or sleeves are used to relieve pain caused due to bone degeneration. These provide pain relief to orthopedic patients. By drug, the bone degeneration therapeutics market is segmented into cortisone or steroids, hyaluronic acid and platelet-rich plasma. Platelet-rich plasma is effective in alleviating pain resulting from arthritis of the knee. Some products such as PREOB and ALLOB (both from Bone Therapeutics SA) are in research pipeline. PREOB received orphan drug designation for osteonecrosis in March 2008 from the U.S. FDA. On the basis of surgery, the bone degeneration therapeutics market is classified as arthroscopy, high tibial osteotomy, and knee replacement. By application, the bone degeneration therapeutics market can be segmented as osteoporosis, osteopenia, and spinal fusion.
Denosumab injection (Prolia) is used to treat osteoporosis in men, post-menopausal women, people with increased risk for fractures, and those who cannot take or do not respond to other medications for osteoporosis. It is also used to treat bone loss in men suffering from prostate cancer and women with breast cancer.
Increasing sports injuries and growing aging population drives growth of the bone degeneration therapeutics market in North America
The market for bone degeneration has significant potential in North America due to high incidence of sport injuries, availability of advanced technology, large aging population, robust medical infrastructure, and favorable government reimbursement policy. According to 2016 estimates of Osteoporosis Canada, over 80% of all fractures reported in people over 50 years of age are caused by osteoporosis and at least one in three women and one in five men suffer from an osteoporotic fracture during their lifetime. Asia Pacific is projected to be a high growth market for bone degeneration in the near future due to increasing consumer health awareness and development of good diagnostic and treatment facilities in the region.
Bone degeneration market: Key players
Amgen, Inc., Fate Therapeutics, Inc., Bone Therapeutics SA, Juventus Therapeutics, Inc., Kaken Pharmaceutical Co., Ltd., Regenexx, and Se-cure Pharmaceuticals, Ltd. are some of the companies involved in development of bone degeneration therapeutic products. Regenexx stem cell and platelet-rich plasma procedures are advanced regenerative injection treatment used to treat knee pain due to arthritis, ligament injuries, and other degenerative conditions.
Get More Details about this Report@
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bone Degeneration Therapeutics Market here
News-ID: 612475 • Views: 457
More Releases from Clinical Diagnostic Report By CMI
Sepsis Diagnostic Market-Global Industry Insights, Trends, Outlook
Sepsis is life threatening complication caused due to the infection, which can result into organ failure, tissue damage, and ultimately lead to death if left untreated. If sepsis progresses to septic shock, it cause sudden drop in blood pressure and may leads to death of patient. Sepsis occurs due the infection in any part of the body. However the most common site of infections leading to the sepsis are lungs,
Liquid Biopsy Market - Insights
Liquid biopsy involves testing of the blood to identify biomarkers or cancer cells in the form of cells or pieces of DNA which are separated from the tumor and are circulating in the blood. Liquid biopsy helps in early detection of cancer, which would aid in adopting an optimal treatment plan. It is a non-invasive technique, which makes frequent testing possible, and effectiveness of cancer treatment can also be validated
Enteric Disease Testing Market - Global Industry Insights 2025
Enteric infection is a type of intestinal disease that causes symptoms ranging from mild gastroenteritis to systemic infections and severe diarrhea. According to WHO in 2017, Infectious gastroenteritis accounts for 1 billion cases of diarrhea globally and over 2 million deaths annually. In addition to this, according to Bill and Melinda Gates Foundation, 2017, enteric and diarrheal diseases leads to death of about 500,000 children, under the age of five
Hospital Acquired Disease Testing Market to Surpass US$ 2.7 Billion by 2025 Glob …
Hospital acquired Disease Testing – Hospital or Mortuary Hospital acquired disease or nosocomial infection is a localized or systemic condition in patients occurred due to adverse reaction caused by infectious toxin agents under medical care and were absent at the time of admission. Hospitals acquired infections results in prolonged hospital stay, antimicrobial resistance, long-term disabilities, and increase mortality rate. Pathogens responsible for nosocomial infections include viruses, fungal parasites, and bacteria. Hospital acquired
More Releases for Bone
Bone Fixation Screw Market
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Bone Fixation Screw Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. The Bone Fixation Screw Market is expected to witness growth in upcoming years due to factors such as increase in target patient population, which mostly includes patients suffering from cancer, tuberculosis and cardiovascular diseases. This market research study determines the increase in changes and the aspects which are likely to have
Bone Implant Market Gaining Momentum Worldwide - CT-Bone, 3D printed Bone Implan …
Market Highlights Bone implant products are used in numerous orthopedic surgeries to support the bone and to restore the functionality of the bone. The increasing geriatric population, growing number of orthopedic surgical procedures, rising prevalence of sports-related injuries, and bone weakness due to the changing lifestyle are the major factors driving the growth of the global bone implant market. Additionally, aggressive strategies adopted by top players and increasing spending on healthcare
Bone Fixation Screw Market
Global Bone Fixation Screw Market Research Report 2018 https://www.qandqmarketresearch.com/reports/bone-fixation-screw-market-26 This report studies the global Bone Fixation Screw market status and forecast, categorizes the global Bone Fixation Screw market size value & volume by key players, type, application, and region. This report focuses on the top players in North America, Europe, AsiaPacific, South America, and Middle East & Africa. Bone fixation is a surgical procedure that stabilizes and fix bone grafts and bone filling
Bone Replacement Products Market– Effective Solution for Bone Problems
The innovative replacement systems are designed to provide patients with a joint preservation ultimatum, preserving the healthy parts of the knee, thus helping to maintain natural knee function. For instance, in 2014, Cayenne Medical launched the Mirror Partial Knee System, the only knee replacement system that uses the patient’s natural knee motion during the surgical procedure. This unique technology balances the knee throughout the entire range of motion. The
Bone Cancer Treatment Market
Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its extremely invasive nature and prolonged duration of disease. Bone cancer is a type of cancer in which the bone tissues grows in an uncontrollable manner. This growth may be benign or malignant. In most cases bone cancer results from other cancers such as lung cancer, kidney cancer, prostate cancer, and breast cancer,
Global Bone Glue Market
The Global Bone Glue Market was valued at US$ 1,648.3 million in 2015 and is projected to expand at a CAGR of 6.3% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Growing incidence of fractures and rapidly aging population are expected to be major factors driving growth of the global bone glue market over the foreseeable future. Each year, an estimated 1.5 million people suffer